Moderna

+$7.96 (+2.30%) Today

+$1.15 (+0.33%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Moderna and other ETFs, options, and stocks.

About MRNA

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics.

CEO

Stéphane Bancel

Employees

1,300

Headquarters

Cambridge, Massachusetts

Founded

2010

MRNA Key Statistics

Market Cap

141.98B

Price-Earnings Ratio

281.98

Dividend Yield

—

Average Volume

30.45M

High Today

$359.88

Low Today

$342.28

Open Price

$346.90

Volume

11.35M

52 Week High

$362.00

52 Week Low

$54.21

MRNA News

BenzingaJul 30

Unusual Options Activity Insight: Moderna - Moderna

Shares of Moderna (NASDAQ:MRNA) saw some unusual options activity on Friday. Following the unusual option alert, the stock price moved up to $355.06. Sentiment

Yahoo FinanceJul 29

AMD CEO on chip shortage: things will improve

Motley Fool For each of the following three ultra-popular stocks, the lowest price target from an analyst on Wall Street implies downside ranging from 50% to a

BenzingaJul 27

Why Moderna Shares Dipped On Tuesday - Moderna

Moderna (NASDAQ:MRNA) shares are trading lower on reports suggesting the company is having supply issues. According to a Reuters report, the company said that

Analyst Ratings

41%

of 17 ratings

Buy

41.2%

Hold

35.3%

Sell

23.5%

MRNA Earnings

-$0.69

$0.49

$1.66

$2.84

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

— per share

Actual

Available Aug 5, Pre-Market